How to File a Belviq Lawsuit
A Belviq lawsuit is filed against the manufacturer, Eisai Inc., because of a possible cancer risk associated with the prescription weight management drug. Because of this danger, the FDA has ordered the withdrawn of Belviq and its generic version, Belviq XR. However, it is possible to get significant financial compensation if you are affected by the cancer caused by this drug. Read on to learn more about the steps you need to take to file a Belviq lawsuit. While the FDA has not confirmed a direct link between Belviq and cancer, there are many lawyers specializing in personal injury lawsuits, and some of these cases have been settled. In most cases, the patient must have been diagnosed with cancer within seven years of taking Belviq, and the cancer must have originated in the pancreas or lung. It cannot have spread to other organs. In order to be eligible to file a Belviq lawsuit the patient must have taken the drug within a year of its diagnosis. When a plaintiff files a lawsuit against the manufacturer, he or she will need to gather all of the relevant information. The drug was studied over three years, and users were required to complete a long-term study to see how it would affect their overall health. The FDA approved a study that included nearly 12,000 patients. Despite this, 7.7 percent of Belviq users were diagnosed with cancer. This increased the number of people filing lawsuits. When you file a Belviq lawsuit, your attorney will want to review your medical records. In many cases, the patient took the drug for six months before they developed cancer. The lawyer will want to know whether the patient had any previous cancer diagnosis. If a prior cancer diagnosis is present, it may increase the risk of developing cancer while taking the drug. Once the cancer has been diagnosed, the patient should discontinue taking the drug and consult a doctor. The plaintiffs' attorneys must be contacted as soon as possible to file a lawsuit. The time frame for filing a lawsuit is critical, as the law allows the time for the process to proceed. The plaintiffs' lawyers must act quickly, because the statute of limitations for filing a Belviq lawsuit is one year and a half old. Consequently, the plaintiffs' attorneys must act promptly to protect their clients' rights. While the number of Belviq lawsuits continues to grow, the FDA has approved the drug. In Europe, however, the European regulators have rejected it. The FDA approved the drug, but European regulators have not approved it. The reasons for these denials are identical. Because of the cancer risks, the company must take action immediately. There is an extremely high risk of cancer, so any delays in filing a Belviq lawsuit can be devastating. |
|
